Your session is about to expire
← Back to Search
Behavioural Intervention
tDCS and CO-OP Group for Stroke
Phase 1
Waitlist Available
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after study completion, an average of 5 weeks
Awards & highlights
Study Summary
This study is evaluating whether a combination of transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) may help individuals with chronic stroke. original
Eligible Conditions
- Stroke
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after study completion, an average of 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after study completion, an average of 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), & Feasibility of Intervention Measure
Client Satisfaction Questionnaire (CSQ-8)
Semi-Structured Interview
Secondary outcome measures
Canadian Occupational Performance Measure (COPM)
Performance Quality Rating Scale (PQRS)
Trial Design
1Treatment groups
Experimental Treatment
Group I: tDCS and CO-OP GroupExperimental Treatment1 Intervention
One-hour session three times per week for 4 weeks. Participants will receive anodal tDCS (1.5 mA) to the dorsolateral prefrontal cortex (dlPFC) for 20 minutes at the beginning of each session. Following each tDCS session, the participants will complete a sensations questionnaire.The basis for each session will be task-based practice of client-chosen goals and the use of cognitive strategies using CO-OP.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
tDCS and CO-OP Group
2020
Completed Phase 1
~10
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
University of Missouri-ColumbiaLead Sponsor
367 Previous Clinical Trials
628,409 Total Patients Enrolled
7 Trials studying Stroke
421 Patients Enrolled for Stroke
Share this study with friends
Copy Link
Messenger